RxDoctor Payments Data

Georgios Georgakis

Surgical Oncology · Stony Brook, NYNPI 1952508038

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (39.3%), education and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 61.8% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2020 at $6,065 and has fallen 85.1% since, to $904 in 2025. Among surgical oncology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,451in general payments, 2019–2025

Across 80 payments — averaging $143.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$7K
  • Medtronic$1K
  • Angiodynamics, Inc.$1K
  • Intera Oncology, Inc$401
  • Ipsen Biopharmaceuticals, Inc$367
  • AbbVie$332
  • plus $891 from 6 others

What the payments were for

  • Travel & lodging$2,93126%
  • Food & beverage$4,50539%
  • Education$4,01535%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,451 in reported general payments places this provider in the 90th percentile of 173 surgical oncology providers in New York.

See all surgical oncology providers in New York

Medicare billing

Part B allowed, 2024
$82,294
Medicare patients
70
Services billed
134

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl14$35

Paid to pharmacies, not to this prescriber.

Other surgical oncology in Stony Brook

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →